The Discounted Cash Flow (DCF) valuation of Haemonetics Corp (HAE) is 92.15 USD. With the latest stock price at 56.83 USD, the upside of Haemonetics Corp based on DCF is 62.1%.
Based on the latest price of 56.83 USD and our DCF valuation, Haemonetics Corp (HAE) is a buy. buying HAE stocks now will result in a potential gain of 62.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 7.9% | 7.0% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 64.69 - 151.37 | 92.15 |
| Upside | 13.8% - 166.4% | 62.1% |